Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis

Clinical Science

Volumn 124, Issue 5, 2013, Pages 307-323

  Haznedaroglu, Ibrahim C ^a   Beyazit, Yavuz ^a,b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Bone marrow; Cancer; Haematopoiesis; Neoplastic disorder; Renin angiotensin system (RAS)

Indexed keywords

ANGIOTENSINOGEN; RENIN;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; APOPTOSIS; BONE MARROW; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DENDRITIC CELL; ERYTHROCYTE; ERYTHROPOIESIS; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE; MACROPHAGE; MAST CELL; MONOCYTE; MYELOPOIESIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTOPOIESIS;

BONE MARROW; HEMATOPOIESIS; HUMANS; LEUKEMIA; RENIN-ANGIOTENSIN SYSTEM;

EID: 84872254065     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120300     Document Type: Review

References (142)

1. Haznedaroglu, I. C., Tuncer, S. and Gursoy, M. (1996) A local renin-angiotensin system in the bone marrow. Med. Hypotheses 46, 507-510
2. Haznedaroglu, I. C. (2004) A local renin-angiotensin system in the bone marrow still awaits its Christopher Columbus. Exp. Hematol. 26, 279
3. Strawn, W. B., Richmond, R. S., Tallant, E. A., Gallagher, P. E. and Ferrario, C. M. (2004) Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br. J. Haematol. 126, 120-126
4. Haznedaroglu, I. C. and Beyazit, Y. (2010) Pathobiological aspects of the local bone marrow renin-angiotensin system: a review. JRAAS 11, 205-213
5. Haznedaroglu, I. C. and Ozturk, M. A. (2003) Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int. J. Biochem. Cell. Biol. 35, 867-880
6. Hubert, C., Savary, K., Gasc, J. M. and Corvol, P. (2006) The hematopoietic system: a new niche for the renin-angiotensin system. Nat. Clin. Cardiovasc. Med. 3, 80-85
7. Lin, C., Datta, V., Okwan-Duodu, D., Chen, X., Fuchs, S., Alsabeh, R., Billet, S., Bernstein, K. E. and Shen, X. Z. (2010) Angiotensin-converting enzyme is required for normal myelopoiesis. FASEB J. 25, 1145-1155
8. Kato, H., Ishida, J., Imagawa, S., Saito, T., Suzuki, N., Matsuoka, T., Sugaya, T., Tanimoto, K., Yokoo, T., Ohneda, O. et al. (2005) Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J. 19, 2023-2025
9. Kwiatkowski, B. A. and Richard, R. E. (2009) Angiotensin II receptor-associated protein (AGTRAP) synergizes with Mpl signaling to promote survival and to increase proliferation rate of hematopoietic cells. ASH Annual Meeting Abstracts 114, 3606
10. Hara, M., Ono, K., Wada, H., Sasayama, S. and Matsumori, A. (2004) Preformed angiotensin II is present in human mast cells. Cardiovasc. Drugs Ther. 18, 415-420
11. Park, T. S. and Zambidis, E. T. (2009) A role for the renin-angiotensin system in hematopoiesis. Haematologica 94, 745-747
12. Shen, X. Z. and Bernstein, K. E. (2011) The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis. Cell Cycle 10, 1363-1369
13. Huang, Y. L., Kuang, J., Hu, Y. Z., Song, Y. B., Qiu, R. F. and Mai, W. Y. (2012) Bone marrow stromal cell transplantation combined with angiotensin-converting enzyme inhibitor treatment in rat with acute myocardial infarction and the role of insulin-like growth factor-1. Cytotherapy 14, 563-569
14. Comte, L., Lorgeot, V., Bignon, J., Volkov, L., Dupuis, F., Wdzieczak-Bakala, J. and Praloran, V. (1998) In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide. Eur. J. Clin. Invest. 28, 856-863
15. Comte, L., Lorgeot, V., Volkov, L., Allegraud, A., Aldigier, J. C. and Praloran, V. (1997) Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations. Eur. J. Clin. Invest. 27, 788-790
16. Li, J., Volkov, L., Comte, L., Herve, P., Praloran, V. and Charbord, P. (1997) Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells. Exp. Hematol. 25, 140-146
17. Oliveira, C. R., Paredes-Gamero, E,J., Barbosa, C. M., Nascimento, F. D., Batista, E. C., Reis, F. C., Martins, A. H., Ferreira, A. T., Carmona, A. K., Pesquero, J. B. et al. (2010) Myelopoiesis modulation by ACE hyperfunction in kinin B1 receptor knockout mice: relationship with AcSDKP levels. Chem.-Biol. Interact. 184, 388-395
18. Haznedaroglu, I. C., Arici, M. and Buyukasik, Y. (2000) A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway. Med. Hypotheses 54, 80-83
19. Ozturk, M. A., Guven, G. S. and Haznedaroglu, I. C. (2004) How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity Impact of local renin-angiotensin systems. Med. Hypotheses 63, 866-874
20. Vrsalovic, M. M., Pejsa, V., Veic, T. S., Kolonic, S. O., Ajdukovic, R., Haris, V., Jaksic, O. and Kusec, R. (2007) Bone marrow renin-angiotensin system expression in polycythemia vera and essential thrombocythemia depends on JAK2 mutational status. Cancer Biol. Ther. 6, 1434-1436
21. Jokubaitis, V. J., Sinka, L., Driessen, R., Whitty, G., Haylock, D. N., Bertoncello, I., Smith, I., Péault, B., Tavian, M. and Simmons, P. J. (2008) Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 111, 4055-4063
22. Sinka, L., Biasch, K., Khazaal, I., Péault, B. and Tavian, M. (2012) Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo. Blood 119, 3712-3723
23. Tavian, M., Biasch, K., Sinka, L., Vallet, J. and Péault, B. (2010) Embryonic origin of human hematopoiesis. Int. J. Dev. Biol. 54, 1061-1065
24. Zambidis, E. T., Soon Park, T., Yu, W., Tam, A., Levine, M., Yuan, X., Pryzhkova, M. and Péault, B. (2008) Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112, 3601-3614
25. Paul, M., Poyan Mehr, A. and Kreutz, R. (2006) Physiology of local renin-angiotensin systems. Physiol. Rev. 86, 747-803
26. Leung, P. S. (2004) The peptide hormone angiotensin II: Its new functions in tissues and organs. Curr. Protein Pept. Sci. 5, 267-273
27. Rodgers, K. E., Xiong, S., Steer, R. and diZerega, G. S. (2000) Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18, 287-294
28. Mehta, P. K. and Griendling, K. K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell. Physiol. 292, C82-C97
29. Ellefson, D. D., diZerega, G. S., Espinoza, T., Roda, N., Maldonado, S. and Rodgers, K. E. (2004) Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother. Pharmacol. 53, 15-24
30. Shi, R. Z., Wang, J. C., Huang, S. H., Wang, X. J. and Li, Q. P. (2009) Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells. Exp. Cell Res. 315, 10-15
31. Li, Y., Zhang, C., Wu, Y., Han, Y., Cui, W., Jia, L., Cai, L., Cheng, J., Li, H. and Du, J. (2012) Interleukin-12p35 deletion promotes CD4 T-cell-dependent macrophage differentiation and enhances angiotensin ii-induced cardiac fibrosis. Arterioscler. Thromb. Vasc. Biol. 32, 1662-1674
32. Durik, M., Seva Pessoa, B. and Roks, A. J. (2012) The renin-angiotensin system, bone marrow and progenitor cells. Clin. Sci. 123, 205-223
33. Heringer-Walther, S., Eckert, K., Schumacher, S. M., Uharek, L., Wulf-Goldenberg, A., Gembardt, F., Fichtner, I., Schultheiss, H. P., Rodgers, K. and Walther, T. (2009) Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 94, 857-860
34. Abali, H., Haznedaroglu, I. C., Goker, H., Celik, I., Ozatli, D., Koray, Z. and Caglar, M. (2002) Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. Hematology 7, 75-82
35. Aksu, S., Beyazit, Y., Haznedaroglu, I. C., Canpinar, H., Kekilli, M., Uner, A., Sayinalp, N., Büyükaşik, Y., Goker, H. and Ozcebe, O. I. (2006) Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk. Lymphoma 47, 891-896
36. Beyazit, Y., Aksu, S., Haznedaroglu, I. C., Kekilli, M., Misirlioglu, M., Tuncer, S., Karakaya, J., Koca, E., Buyukasik, Y., Sayinalp, N. and Goker, H. (2007) Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J. Natl. Med. Assoc. 99, 57-63
37. Tufan, A., Unal, N., Koca, E., Onal, I., Aksu, S. and Haznedaroglu, I. (2006) Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome. Ann. Hematol. 85, 183-184
38. Sayinalp, N., Cinar, H., Uner, A., Haznedaroǧlu, I. C., Büyükaşik, Y., Göker, H., Aksu, S., Ozcebe, O. I., Karakuş, S., Kirazli, S. and Dündar, S. V. (2004) Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders. Clin. Lab. Haematol. 26, 265-268
39. Dizdar, O., Yurekli, B. S., Purnak, T., Aksu, S. and Haznedaroglu, I. C. (2004) Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia. Ann. Pharmacother. 38, 1319-1320
40. Aksu, S., Beyazit, Y., Haznedaroglu, I. C., Kekilli, M., Canpinar, H., Misirlioǧlu, M., Uner, A., Tuncer, S., Sayinalp, N., Büyükaşik, Y., Goker, H. and Ozcebe, I. H. (2005) Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia Rubra vera. J. Int. Med. Res. 33, 661-667
41. Teresa Gomez Casares, M., de la Iglesia, S., Perera, M., Lemes, A., Campo, C., Gonzalez San Miguel, J. D., Bosch, J. M., Suarez, A., Guerra, L., Rodriguez-Peréz, J. C. and Molero, T. (2002) Renin expression in hematological malignancies and its role in the regulation of hematopoiesis. Leuk. Lymphoma 43, 2377-2381
42. Iñigo Sde, L., Casares, M. T., Jorge, C. E., Leiza, S. M., Santana, G. S., Bravo de Laguna, S. J., San Miguel, J. D., Caballero, A., Alvarez Mdel, M., Castellano, A. L. et al. (2006) Relevance of renin expression by real-time PCR in acute myeloid leukemia. Leuk. Lymphoma 47, 409-416
43. + cells of peripheral blood and bone marrow in acute leukemia patients in the course of induction chemotherapy. Ter. Arkh. 83, 32-37
44. Wulf, G. G., Jahns-Streubel, G., Nobiling, R., Strutz, F., Hemmerlein, B., Hiddemann, W. and Wörmann, B. (1998) Renin in acute myeloid leukaemia blasts. Br. J. Haematol. 100, 335-337
45. Koca, E., Haznedaroglu, I. C., Acar, K., Beyazit, Y., Aksu, S., Misirlioglu, M., Tuncer, S., Sayinalp, N., Ozcebe, O. I. and Uner, A. (2007) Renin-angiotensin system expression in the K562 human erythroleukaemic cell line. JRAAS 8, 145-147
46. Pinto, R. P., Wang, K. K., Khoury, H., Schimmer, A. D. and Minden, M. D. (2004) aberrant expression of angiotensin in acute myeloid leukemia. Blood 102, 2124A
47. De la Iglesia Iñigo, S., López-Jorge, C. E., Gómez-Casares, M. T., Lemes Castellano, A., Martín Cabrera, P., López Brito, J., Súarez Cabrera, A. and Molero Labarta, T. (2009) Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents. Leuk. Res. 33, 810-816
48. Rodgers, K., Xiong, S. and DiZerega, G. S. (2003) Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother. Pharmacol. 51, 97-106
49. Rodgers, K. E., Oliver, J. and diZerega, G. S. (2006) Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother. Pharmacol. 57, 559-568
50. Abali, H., Gullu, I. H., Engin, H., Haznedaroǧlu, I. C., Erman, M. and Tekuzman, G. (2002) Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med. Hypotheses 59, 344-348
51. Marusic-Vrsalovic, M., Dominis, M., Jaksic, B. and Kusec, R. (2003) Angiotensin I-converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow. Br. J. Haematol. 123, 539-541
52. Tsubakimoto, Y., Yamada, H., Yokoi, H., Kishida, S., Takata, H., Kawahito, H., Matsui, A., Urao, N., Nozawa, Y., Hirai, H. et al. (2009) Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells. Arterioscler. Thromb. Vasc. Biol. 29, 1529-1536
53. Richmond, R. S., Tallant, E. A., Gallagher, P. E., Ferrario, C. M. and Strawn, W. B. (2004) Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. JRAAS 5, 176-182
54. Gomez, R. A., Norling, L. L., Wilfong, N., Isakson, P., Lynch, K. R., Hock, R. and Quesenberry, P. (1993) Leukocytes synthesize angiotensinogen. Hypertension 21, 470-475
55. Rodgers, K. E., Espinoza, T., Roda, N., Meeks, C. J., Hill, C., Louie, S. G. and Dizerega, G. S. (2012) Accelerated hematopoietic recovery with angiotensin-(1-7) after total body radiation. Int. J. Radiat. Biol. 88, 466-476
56. Rodgers, K. E., Xiong, S. and diZerega, G. S. (2002) Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemother. Pharmacol. 49, 403-411
57. Cole, J., Ertoy, D. and Bernstein, K. E. (2000) Insights derived from ACE knockout mice. JRAAS 1, 137-141
58. Cole, J., Ertoy, D., Lin, H., Sutliff, R. L., Ezan, E., Guyene, T. T., Capecchi, M., Corvol, P. and Bernstein, K. E. (2000) Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J. Clin. Invest. 106, 1391-1398
59. Kaneko, K., Nishiyama, H., Ohba, K., Shibasaki, A., Hirose, T., Totsune, K., Furuyama, K. and Takahashi, K. (2012), Expression of (pro)renin receptor in human erythroid cell lines and its increased protein accumulation by interferon-γ. Peptides 37, 285-289
60. Mrug, M., Julian, B. A. and Prchal, J. T. (2004) Angiotensin II receptor type 1 expression in erythroid progenitors: Implications for the pathogenesis of postrenal transplant erythrocytosis. Semin. Nephrol. 24, 120-130
61. Mrug, M., Stopka, T., Julian, B. A., Prchal, J. F. and Prchal, J. T. (1997) Angiotensin II stimulates proliferation of normal early erythroid progenitors. J. Clin. Invest. 100, 2310-2314
62. Batenburg, W. W. and Danser, A. H. (2012) (Pro)renin and its receptors: pathophysiological implications. Clin. Sci. 123, 121-133
63. De Mello, W. C. (2006) On the pathophysiological implications of an intracellular renin receptor. Circ. Res. 99, 1285-1286
64. + cells and early erythropoiesis. Oncogene 28, 2276-2288
65. Wang, N., Frank, G. D., Ding, R., Tan, Z., Rachakonda, A., Pandolfi, P. P., Senbonmatsu, T., Landon, E. J. and Inagami, T. (2012) Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin ii receptor 2. PLoS ONE 7, e35632
66. Savary, K., Michaud, A., Favier, J., Larger, E., Corvol, P. and Gasc, J. M. (2005) Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo. Blood 105, 103-110
67. Marathias, K. P., Agroyannis, B., Mavromoustakos, T., Matsoukas, J. and Vlahakos, D. V. (2004) Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Curr. Top. Med. Chem. 4, 483-486
68. Haznedaroglu, I. C., Goker, H., Turgut, M., Buyukasik, Y. and Benekli, M. (2002) Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions. Clin. Appl. Thromb. Hemostasis 8, 193-212
69. Ishikawa, M., Sekizuka, E., Yamaguchi, N., Nakadate, H., Terao, S., Granger, D. N. and Minamitani, H. (2007) Angiotensin II type 1 receptor signaling contributes to platelet-leukocyteendothelial cell interactions in the cerebral microvasculature. Am. J. Physiol. Heart Circ. Physiol. 292, H2306-H2315
70. Larsson, P. T., Schwieler, J. H. and Wallen, N. H. (2000) Platelet activation during angiotensin II infusion in healthy volunteers. Blood. Coagul. Fibrinolysis 11, 61-69
71. Stegbauer, J., Lee, D. H., Seubert, S., Ellrichmann, G., Manzel, A., Kvakan, H., Muller, D. N., Gaupp, S., Rump, L. C., Gold, R. and Linker, R. A. (2009) Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 106, 14942-14947
72. Nahmod, K., Gentilini, C., Vermeulen, M., Uharek, L., Wang, Y., Zhang, J., Schultheiss, H. P., Geffner, J. and Walther, T. (2010) Impaired function of dendritic cells deficient in angiotensin II type 1 receptors. J. Pharmacol. Exp. Ther. 334, 854-862
73. Nahmod, K. A., Geffner, J. R. and Walther, T. (2010) Angiotensin II type 1a-deficient bone marrow-derived dendritic cells produce higher levels of monocyte chemoattractant protein 1. Hypertension 56, e6-7
74. Nahmod, K. A., Vermeulen, M. E., Raiden, S., Salamone, G., Gamberale, R., Ferńandez-Calotti, P., Alvarez, A., Nahmod, V., Giordano, M. and Geffner, J. R. (2003) Control of dendritic cell differentiation by angiotensin II. FASEB J. 17, 491-493
75. Tavian, M. and Peault, B. (2005) The changing cellular environments of hematopoiesis in human development in utero. Exp. Hematol. 33, 1062-1069
76. Hirschi, K. K. (2012) Hemogenic endothelium during development and beyond. Blood 119, 4823-4827
77. Xing, Y., Lv, A. and Wang, L. (2011) The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol. Cell. Biochem. 360, 279-287
78. Sequeira Lopez, M. L. and Gomez, R. A. (2004) The role of angiotensin II in kidney embryogenesis and kidney abnormalities. Curr. Opin. Nephrol. Hypertens. 13, 117-122
79. Ager, E. I., Neo, J. and Christophi, C. (2008) The reninangiotensin system and malignancy. Carcinogenesis 29, 1675-1684
80. George, A. J., Thomas, W. G. and Hannan, R. D. (2012) The renin-angiotensin system and cancer: old dog, new tricks. Nat. Rev. Cancer 10, 745-759
81. Ni, L., Feng, Y., Wan, H., Ma, Q., Fan, L., Qian, Y., Li, Q., Xiang, Y. and Gao, B. (2012) Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol. Rep. 27, 783-790
82. Okamoto, K., Tajima, H., Ohta, T., Nakanuma, S., Hayashi, H., Nakagawara, H., Onishi, I., Takamura, H., Ninomiya, I., Kitagawa, H. et al. (2012) Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells. Int. J. Oncol. 37, 1251-1259
83. Schmid, U., Stopper, H., Schweda, F., Queisser, N. and Schupp, N. (2008) Angiotensin II induces dna damage in the kidney. Cancer Res. 68, 9239-9246
84. Fendrich, V., Chen, N. M., Neef, M., Waldmann, J., Buchholz, M., Feldmann, G., Slater, E. P., Maitra, A. and Bartsch, D. K. (2010) The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Gut 59, 630-637
85. Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y. and Jain, R. K. (2011) Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc. Natl. Acad. Sci. U.S.A. 108, 2909-2914
86. Velez Rueda, J. O., Palomeque, J. and Mattiazzi, A. (2012) Early apoptosis in different models of cardiac hypertrophy induced by high renin-angiotensin system activity involves CaMKII. J. Appl. Physiol. 112, 2110-2120
87. Wang, X., Lu, J., Khaidakov, M., Mitra, S., Ding, Z., Goyal, T. and Mehta, J. L. (2012) Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis. Apoptosis 17, 908-915
88. Yang, C., Wang, Y., Liu, H., Li, N., Sun, Y., Liu, Z. and Yang, P. (2012) Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway. J. Cardiovasc. Pharmacol. 59, 465-471
89. Lo, C. S., Liu, F., Shi, Y., Maachi, H., Chenier, I., Godin, N., Filep, J. G., Ingelfinger, J. R., Zhang, S. L. and Chan, J. S. (2012) Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am. J. Physiol. Renal Physiol. 302, F840-F852
90. Matsushita, K., Wu, Y. J., Okamoto, Y., Pratt, R. E. and Dzau, V. J. (2006) Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48, 1095-1102
91. Ishizuka, T., Goshima, H., Ozawa, A. and Watanabe, Y. (2012) Effect of angiotensin II on proliferation and differentiation of mouse induced pluripotent stem cells into mesodermal progenitor cells. Biochem. Biophys. Res. Commun. 420, 148-155
92. Peters, B., Podlich, D., Ritter, M., Müller, A., Wanka, H., Maser-Gluth, C., Seitz, C., de Boni, L., Maier, E., Gretz, N., Peters, J. and Hoffmann, S. C. (2012) A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex. Am. J. Physiol. Endocrinol. Metab. 15, E1044-E1054
93. Du, N., Feng, J., Hu, L. J., Sun, X., Sun, H. B., Zhao, Y., Yang, Y. P. and Ren, H. (2012) Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol. Rep. 27, 1893-1903
94. Gwathmey, T. M., Alzayadneh, E. M., Pendergrass, K. D. and Chappell, M. C. (2011) Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R518-R530
95. Vitko, J. R., Re, R. N., Alam, J. and Cook, J. L (2012) Cell-penetrating peptides corresponding to the angiotensin II Type 1 receptor reduce receptor accumulation and cell surface expression and signaling. Am. J. Hypertens. 25, 24-28
96. Rodgers, K. E., Xiong, S., Steer, R. and diZerega, G. S. (2000) Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18, 287-294
97. McCollum, L. T., Gallagher, P. E. and Tallant, E. A. (2012) Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts. Peptides 34, 380-388
98. Carbajo-Lozoya, J., Lutz, S., Feng, Y., Kroll, J., Hammes, H. P. and Wieland, T. (2012) Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Cell. Signalling 24, 1261-1269
99. Wang, Q., Lei, X., Zhu, S. and Zhang, S. (2012) Angiotensin-I converting enzyme inhibitors suppress angiogenesis and growth of esophageal carcinoma xenografts. Dis. Esophagus, doi:10.1111/j.1442-2050.2011.01320.x
100. Kaji, K., Yoshiji, H.,Ikenaka, Y., Noguchi, R., Aihara, Y., Shirai, Y., Douhara, A. and Fukui, H. (2012) Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress. Curr. Med. Chem. 19, 1889-1898
101. Jethon, A., Pula, B., Piotrowska, A., Wojnar, A., Rys, J., Dziegiel, P. and Podhorska-Okolow, M. (2012) Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer. Pathol. Oncol. Res., 18, 867-873
102. Vinson, G. P., Barker, S. and Puddefoot, J. R. (2011) The renin-angiotensin system in the breast and breast cancer. Endocr. Relat. Cancer 19, R1-R19
103. Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V. and Egido, J. (2003) Inflammation and angiotensin II. Int. J. Biochem. Cell. Biol. 35, 881-900
104. Röcken, C., Lendel, U., Dierkes, J., Westphal, S., Carl-McGrath, S., Peters, B., Krüger, S., Malfertheiner, P., Roessner, A. and Ebert, M. P. (2005) The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin. Cancer Res. 11, 2526-2530
105. Yaren, A., Oztop, I., Turgut, S., Turgut, G., Degirmencioglu, S. and Demirpence, M. (2008) Angiotensin-converting enzyme gene polymorphism is associated with anemia in non-small-cell lung cancer. Exp. Biol. Med. 233, 32-37
106. Yaren, A., Turgut, S., Kursunluoglu, R., Oztop, I., Turgut, G., Degirmencioglu, S., Kelten, C. and Erdem, E. (2007) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J. Investig. Med. 55, 255-261
107. Yigit, B., Bozkurt, N., Narter, F., Yilmaz, H., Yucebas, E. and Isbir, T. (2007) Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer Res. 27, 933-936
108. Rocken, C., Rohl, F. W., Diebler, E., Lendeckel, U., Pross, M., Carl-McGrath, S. and Ebert, M. P. (2007) The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol. Biomarkers Prev. 16, 1206-1212
109. Dević Pavlić, S., Ristić, S., Flego, V., Kapović, M. and Radoǰcić Badovinac, A. (2012) Angiotensin-converting enzyme insertion/deletion gene polymorphism in lung cancer patients. Genet. Test. Mol. Biomarkers 16, 722-725
110. Rodrigues-Ferreira, S., Abdelkarim, M., Dillenburg-Pilla, P., Luissint, A. C., di-Tommaso, A., Deshayes, F., Pontes, C. L., Molina, A., Cagnard, N., Letourneur, F. et al. (2012) Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS ONE 7, e35667
111. Jurewicz, M., McDermott, D. H., Sechler, J. M., Tinckam, K., Takakura, A., Carpenter, C. B., Milford, E. and Abdi, R. (2007) Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J. Am. Soc. Nephrol. 18, 1093-1102
112. Shen, X. Z., Li, P., Weiss, D., Fuchs, S., Xiao, H. D., Adams, J. A., Williams, I. R., Capecchi, M. R., Taylor, W. R. and Bernstein, K. E. (2007) Mice with enhanced macrophage angiotensinconverting enzyme are resistant to melanoma. Am. J. Pathol. 170, 2122-2134
113. Shen, X. Z., Billet, S., Lin, C., Okwan-Duodu, D., Chen, X., Lukacher, A. E. and Bernstein, K. E. (2012) The carboxypeptidase angiotensin converting enzyme (ACE) shapes the MHC class I peptide repertoire. Nat. Immunol. 12, 1078-1085
114. Wulf, G. G., Jahns-Streubel, G., Strutz, F., Basenau, D., Hüfner, M., Buske, C., Wörmann, B. and Hiddemann, W. (1996) Paraneoplastic hypokalemia in acute myeloid leukemia: A case of renin activity in AML blast cells. Ann. Hematol. 73, 139-141
115. Haznedaroglu, I. C., Savas, M. C. and Benekli, M. (1997) Renin-like activity in leukemic blast cells: an initial clue to a local renin-angiotensin system in the bone marrow. Ann. Hematol. 75, 69-70
116. + hematopoietic cells. Cancer Res. 66, 6628-6637
117. + cells: role of a conserved helicase motif. Leukemia 24, 1001-1011
118. Koca, E., Haznedaroglu, I. C., Uner, A., Sayinalp, N., Saglam, A. E., Goker, H. and Ozcebe, O. I. (2007) Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease. J. Natl. Med. Assoc. 99, 1243-1244, 1246-1247
119. Albayrak, M., Celebi, H., Albayrak, A., Sayilir, A., Yesil, Y., Balcik, O. S., Yokus, O. and Celik, T. (2012) Elevated serum angiotensin converting enzyme levels as a reflection of bone marrow renin-angiotensin system activation in multiple myeloma. JRAAS 13, 259-64
120. Saka, B., Dogan, O., Tascioglu, C., Besisik, S. K., Karan, M. A., Sayitoglu, M., Erten, N. and Genc, S. (2009) Bone marrow renin-angiotensin system in multiple myeloma. Clin. Lymphoma Myeloma Leuk. 9 (Suppl. 1), S10
121. Brunet de la Grange, P., Ivanovic, Z., Leprivey-Lorgeot, V. and Praloran, V. (2002) Angiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented medium. Stem Cells 20, 269-271
122. Akalin, I., Koca, E., Karabulut, H. G., Haznedaroglu, I. C., Cetiner, D., Hayran, M., Onal, I. K., Ozcebe, O. I. and Tukun, A. (2011) Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphisms in leukemic hematopoiesis. Int. J. Hematol. Oncol. 21, 1-9
123. Goker, H., Haznedaroglu, I. C., Beyazit, Y., Aksu, S., Tuncer, S., Misirlioglu, M., Bayramoglu, F., Kekilli, M., Büyükasik, Y., Sayinalp, N. et al. (2005) Local umbilical cord blood renin-angiotensin system. Ann. Hematol. 84, 277-81
124. Sayitoglu, M., Haznedaroǧlu, I. C., Hatirnaz, O., Erbilgin, Y., Aksu, S., Koca, E., Adiguzel, C., Bayik, M., Akalin, I., Gülbas, Z. et al. (2009) Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia. J. Int. Med. Res. 37, 1018-1028
125. Beyazit, Y., Purnak, T., Guven, G. S. and Haznedaroglu, I. C. (2010) Local bone marrow renin-angiotensin system and atherosclerosis. Cardiol. Res. Pract. 2011, 714515
126. Ferrario, C. M., Richmond, R. S., Smith, R., Levy, P., Strawn, W. B. and Kivlighn, S. (2004) Renin-angiotensin system as a therapeutic target in managing atherosclerosis. Am. J. Ther. 11, 44-53
127. Fukuda, D. and Sata, M. (2008) Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis. Pharmacol. Ther. 118, 268-276
128. Fukuda, D., Sata, M., Ishizaka, N. and Nagai, R. (2008) Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 90-96
129. Kato, H., Ishida, J., Nagano, K., Honjo, K., Sugaya, T., Takeda, N., Sugiyama, Y., Yagami, K., Fujita, T., Nangaku, M. and Fukamizu, A. (2008) Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Lab. Invest. 88, 731-739
130. Sata, M. and Fukuda, D. (2010) Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J. Med. Invest. 57, 12-25
131. Matsubara, H. (2007) Clinical pathology and treatment of renin-angiotensin system - 3. Atherosclerosis and the renin-angiotensin system. Intern. Med. 46, 1299-1301
132. Strawn, W., Richmond, R. and Ferrario, C. (2003) A new understanding of atherosclerosis: the bone marrow response-to-lipid hypothesis. In: Heart Disease: Pathogenesis, Diagnosis and Treatment, pp. 183-188, Third World Congress on Heart Disease, Washington, DC
133. Strawn, W. B. and Ferrario, C. M. (2008) Angiotensin II AT(1) receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys. Atherosclerosis 196, 624-632
134. Stegbauer, J. and Coffman, T. M. (2011) New insights into angiotensin receptor actions: from blood pressure to aging. Curr. Opin Nephrol. Hypertens. 20, 84-88
135. Purclutepe, O., Iskender, G., Kiper, H. D., Tezcanli, B., Selvi, N., Avci, C. B., Kosova, B., Gokbulut, A. A., Sahin, F., Baran, Y. and Saydam, G. (2012) Enalapril-induced apoptosis of acute promyelocytic leukaemia cells involves STAT5A. Anticancer Res. 32, 2885-2893
136. Bhaskaran, K., Douglas, I., Evans, S., van Staa, T. and Smeeth, L. (2012) Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database. BMJ 344, e2697
137. Gao, M., Wang, Y., Shi, Y., Liu, D., Liang, Y., Yu, Y., Zhaobin, J., Zhu, L. and Jin, S. (2012) The relationship between three well-characterized polymorphisms of the angiotensin converting enzyme gene and lung cancer risk: a case-control study and a meta-analysis. JRAAS, doi: 10.1177/1470320312443912
138. Hallas, J., Depont, C., Christensen, R., Andersen, M., Friis, S. and Bjerrum, L. (2012) Long-term use of drugs affecting the renin-angiotensin system and the risk of cancer. A populationbased case-control study. Br. J. Clin. Pharmacol. 74, 180-188
139. McMenamin, U. C., Murray, L. J., Cantwell, M. M. and Hughes, C. M. (2011) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes Control 23, 221-230
140. Liu, J. M., Lawrence, F., Kovacevic, M., Bignon, J., Papadimitriou, E., Lallemand, J. Y., Katsoris, P., Potier, P., Fromes, Y. and Wdzieczak-Bakala, J. (2003) The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 101, 3014-3020
141. Cheng, C. I., Hsiao, C. C., Wu, S. C., Peng, S. Y., Yip, H. K., Fu, M. and Wang, W. S. (2012) Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway. Int. J. Cardiol., doi:10.1016/j.ijcard.2012.06.128
142. Kawabata, A., Baoum, A., Ohta, N., Jacquez, S., Seo, G. M., Berkland, C. and Tamura, M. (2012) Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res. 72, 2057-2067